<DOC>
	<DOCNO>NCT02777723</DOCNO>
	<brief_summary>The purpose study compare efficacy safety CKD-350 patient dry eye syndrome</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety CKD-350</brief_title>
	<detailed_description>Active control , randomize , double-blind , multi-center , phase 3 trial evaluate efficacy safety CKD-350 eye drop patient dry eye syndrome</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . More age 19 year old 2 . Subjects dry eye symptom least 3 month prior screen 3 . Subjects follow value 1 ) ≥ 2 point corneal stain score 2 ) ≤ 10 second Tear Breakup Time 3 ) ≤10mm/5min Schirmer I Test 4 . Subjects visual acuity equal well 0.2 eye 5 . Subjects sign inform consent form willingly 1 . Subjects clinically significant ocular surface disease , abnormal corneal susceptibility abnormal epiphora 2 . Subjects medical history follow 1 ) Abnormal eyelid function include abnormality eyelid eyelash 2 ) Ophthalmology operation within 1 year 3 ) Active ocular infection present treatment allergic eye diseases 4 ) Herpetic keratopathy , conjunctiva scar cicatricial keratoconjunctivitis ( alkali injury , stevensjohnson syndrome , ocular cicatricial pemphigoid ) , pterygium , congenital lacrimal gland absence , neural keratitis , keratoconus 3 . Subjects receive occlusion therapy lacrimal punctal plug within 3 month surgery plan clinical trial 4 . Subjects wear contact lens within 3 month need wear contact lenses study 5 . Subjects take steroidal immunosuppressive drug within 1 month 6 . Over 22mmHg IOP ( Intraocular Pressure ) 7 . Subjects malignant tumor within 5 year 8 . Subjects know hypersensitivity investigational product 9 . Women nurse , pregnant planning pregnancy study 10 . Subjects receive investigational product within 1 month prior first dose 11 . Impossible subject participate clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dry Eye Syndrome</keyword>
	<keyword>Sodium Hyaluronate</keyword>
	<keyword>CKD-350</keyword>
</DOC>